Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on Invested CapitalReturn on SalesTimes Interest Earned

Qiagen (QGEN) EBITDA Margin (2016 - 2025)

Historic EBITDA Margin for Qiagen (QGEN) over the last 17 years, with Q4 2025 value amounting to 18.4%.

  • Qiagen's EBITDA Margin fell 44500.0% to 18.4% in Q4 2025 from the same period last year, while for Dec 2025 it was 22.29%, marking a year-over-year increase of 173500.0%. This contributed to the annual value of 22.29% for FY2025, which is 127200.0% up from last year.
  • Per Qiagen's latest filing, its EBITDA Margin stood at 18.4% for Q4 2025, which was down 44500.0% from 24.25% recorded in Q3 2025.
  • In the past 5 years, Qiagen's EBITDA Margin ranged from a high of 32.95% in Q1 2022 and a low of 46.02% during Q2 2024
  • For the 5-year period, Qiagen's EBITDA Margin averaged around 19.85%, with its median value being 22.59% (2024).
  • In the last 5 years, Qiagen's EBITDA Margin crashed by -673300bps in 2024 and then skyrocketed by 688700bps in 2025.
  • Quarter analysis of 5 years shows Qiagen's EBITDA Margin stood at 29.73% in 2021, then fell by -29bps to 21.0% in 2022, then increased by 3bps to 21.72% in 2023, then rose by 5bps to 22.85% in 2024, then dropped by -19bps to 18.4% in 2025.
  • Its EBITDA Margin was 18.4% in Q4 2025, compared to 24.25% in Q3 2025 and 22.85% in Q2 2025.